Antipsychotic Drug Use and the Risk of Seizures: Follow-up Study with a Nested Case-Control Analysis

CNS Drugs

Volumn 29, Issue 7, 2015, Pages 591-603

  Bloechliger, Marlene ^a   Rüegg, Stephan ^b   Jick, Susan S ^c   Meier, Christoph R ^a,b,c   Bodmer, Michael ^a,d  

^a UNIVERSITY OF BASEL   (Switzerland)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

^c BOSTON UNIVERSITY   (United States)

^d Medical Department   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMISULPRIDE; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ARIPIPRAZOLE; BENZODIAZEPINE DERIVATIVE; BETA LACTAM ANTIBIOTIC; CHLORPROMAZINE; FLUPENTIXOL; HALOPERIDOL; OLANZAPINE; OPIATE; PERICIAZINE; PROCHLORPERAZINE; PROMAZINE; QUETIAPINE; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; SULPIRIDE; THIORIDAZINE; TRICYCLIC ANTIDEPRESSANT AGENT; TRIFLUOPERAZINE; ZUCLOPENTHIXOL; NEUROLEPTIC AGENT;

ADULT; AGE; ARTICLE; CASE CONTROL STUDY; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DEMENTIA; DRUG POTENCY; DRUG USE; FEMALE; FOLLOW UP; GENDER; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL PATIENT; MIGRAINE; MOOD DISORDER; OBSESSIVE COMPULSIVE DISORDER; PARKINSON DISEASE; PRIORITY JOURNAL; RISK ASSESSMENT; SCHIZOPHRENIA; SEIZURE; SMOKING; SUICIDAL IDEATION; SUICIDE ATTEMPT; TRANSIENT ISCHEMIC ATTACK; ADOLESCENT; AGED; FACTUAL DATABASE; GREAT BRITAIN; INCIDENCE; MIDDLE AGED; MOOD DISORDERS; ODDS RATIO; PATHOPHYSIOLOGY; RETROSPECTIVE STUDY; RISK; SEIZURES; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIPSYCHOTIC AGENTS; CASE-CONTROL STUDIES; DATABASES, FACTUAL; DEMENTIA; FEMALE; FOLLOW-UP STUDIES; GREAT BRITAIN; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MOOD DISORDERS; ODDS RATIO; RETROSPECTIVE STUDIES; RISK; SCHIZOPHRENIA; SEIZURES; YOUNG ADULT;

EID: 84940581513     PISSN: 11727047     EISSN: 11791934     Source Type: Journal    
DOI: 10.1007/s40263-015-0262-y     Document Type: Article

References (34)

1. Meyer JM. Pharmacotherapy of psychosis and mania. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman and Gilman's pharmacological basis of therapeutics. 12th ed. New York: McGrawHill Medical; 2011. p. 417-51.
2. Block F, Dafotakis M. Drug-induced seizures. Fortschr Neurol Psychiatr. 2013;81:28-34. doi: 10.1055/s-0032-1325332.
3. Pisani F, Oteri G, Costa C, Di Raimondo G, Di Perri R. Effects of psychotropic drugs on seizure threshold. Drug Saf. 2002;25:91-110.
4. Ruffmann C, Bogliun G, Beghi E. Epileptogenic drugs: a systematic review. Expert Rev Neurother. 2006;6:575-89. doi: 10.1586/14737175.6.4.575.
5. Itil TM, Soldatos C. Epileptogenic side effects of psychotropic drugs: practical recommendations. JAMA. 1980;244:1460-3.
6. Logothetis J. Spontaneous epileptic seizures and electroencephalographic changes in the course of phenothiazine therapy. Neurology. 1967;17:869-77.
7. Fitzsimons J, Berk M, Lambert T, Bourin M, Dodd S. A review of clozapine safety. Expert Opin Drug Saf. 2005;4:731-44. doi: 10.1517/14740338.4.4.731.
8. Hedges D, Jeppson K, Whitehead P. Antipsychotic medication and seizures: a review. Drugs Today (Barc). 2003;39:551-7.
9. Alper K, Schwartz KA, Kolts RL, Khan A. Seizure incidence in psychopharmacological clinical trials: an analysis of Food and Drug Administration (FDA) summary basis of approval reports. Biol Psychiatry. 2007;62:345-54. doi: 10.1016/j.biopsych.2006.09.023.
10. Williams AM, Park SH. Seizure associated with clozapine: incidence, etiology, and management. CNS Drugs. 2015;29:101-11. doi: 10.1007/s40263-014-0222-y.
11. Kumlien E, Lundberg PO. Seizure risk associated with neuroactive drugs: data from the WHO adverse drug reactions database. Seizure. 2010;19:69-73. doi: 10.1016/j.seizure.2009.11.005.
12. Lertxundi U, Hernandez R, Medrano J, Domingo-Echaburu S, García M, Aguirre C. Antipsychotics and seizures: higher risk with atypicals? Seizure. 2013;22:141-3. doi: 10.1016/j.seizure.2012.10.009.
13. Jick H. A database worth saving. Lancet. 1997;350:1045-6. doi: 10.1016/S0140-6736(05)70451-7.
14. Lawson DH, Sherman V, Hollowell J. The general practice research database: Scientific and Ethical Advisory Group. QJM. 1998;91:445-52.
15. Wood L, Martinez C. The general practice research database: role in pharmacovigilance. Drug Saf. 2004;27:871-81.
16. The Clinical Practice Research Datalink. http://www.cprd.com. Accessed 15 July 2015.
17. Herrett E, Thomas SL, Schoonen WM, Smeeth L, Hall AJ. Validation and validity of diagnoses in the general practice research database: a systematic review. Br J Clin Pharmacol. 2010;69:4-14. doi: 10.1111/j.1365-2125.2009.03537.x.
18. Khan NF, Harrison SE, Rose PW. Validity of diagnostic coding within the general practice research database: a systematic review. Br J Gen Pract. 2010;60:e128-36. doi: 10.3399/bjgp10X483562.
19. Ishiguro C, Wang X, Li L, Jick S. Antipsychotic drugs and risk of idiopathic venous thromboembolism: a nested case-control study using the CPRD. Pharmacoepidemiol Drug Saf. 2014;23:1168-75. doi: 10.1002/pds.3699.
20. Brauer R, Smeeth L, Anaya-Izquierdo K, Timmis A, Denaxas SC, Farrington CP, et al. Antipsychotic drugs and risks of myocardial infarction: a self-controlled case series study. Eur Heart J. 2015;36(16):984-92. doi: 10.1093/eurheartj/ehu263.
21. Laredo L, Vargas E, Blasco AJ, Aguilar MD, Moreno A, Portolés A. Risk of cerebrovascular accident associated with use of antipsychotics: population-based case-control study. J Am Geriatr Soc. 2011;59:1182-7. doi: 10.1111/j.1532-5415.2011.03479.x.
22. Imfeld P, Bodmer M, Schuerch M, Jick SS, Meier CR. Seizures in patients with Alzheimer's disease or vascular dementia: a population-based nested case-control analysis. Epilepsia. 2013;54:700-7. doi: 10.1111/epi.12045.
23. Martinez C, Sullivan T, Hauser WA. Prevalence of acute repetitive seizures (ARS) in the United Kingdom. Epilepsy Res. 2009;87:137-43. doi: 10.1016/j.eplepsyres.2009.08.006.
24. Gasse C, Derby L, Vasilakis-Scaramozza C, Jick H. Incidence of first-time idiopathic seizures in users of tramadol. Pharmacotherapy. 2000;20:629-34.
25. Jick SS, Jick H, Knauss TA, Dean AD. Antidepressants and convulsions. J Clin Psychopharmacol. 1992;12:241-5.
26. Nasrallah H, Tandon R. Classic antipsychotic medications. In: Schatzberg A, Nemeroff C (eds) The American psychiatric publishing textbook of psychopharmacology, 4th edn. Arlington; 2009. p. 533-54.
27. Hesdorffer DC, Ishihara L, Mynepalli L, Webb DJ, Weil J, Hauser WA. Epilepsy, suicidality, and psychiatric disorders: a bidirectional association. Ann Neurol. 2012;72:184-91. doi: 10.1002/ana.23601.
28. Hyde TM, Weinberger DR. Seizures and schizophrenia. Schizophr Bull. 1997;23:611-22.
29. World Health Organization. ATC/DDD Index 2015. 2015. http://www.whocc.no/atc-ddd-index/. Accessed 15 July 2015.
30. Wilden JA, Cohen-Gadol AA. Evaluation of first nonfebrile seizures. Am Fam Physician. 2012;86:334-40.
31. Lee KC, Finley PR, Alldredge BK. Risk of seizures associated with psychotropic medications: emphasis on new drugs and new findings. Expert Opin Drug Saf. 2003;2:233-47.
32. Koch-Stoecker S. Antipsychotic drugs and epilepsy: indications and treatment guidelines. Epilepsia. 2002;43(Suppl 2):19-24.
33. National Institute for Health and Care Excellence. Low-dose antipsychotics in people with dementia. 2015. http://www.nice.org.uk/advice/ktt7/resources/non-guidance-lowdose-antipsychotics-in-people-with-dementia-pdf. Accessed 15 July 2015.
34. Devinsky O, Honigfeld G, Patin J. Clozapine-related seizures. Neurology. 1991;41:369-71.